Board of Directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol-Myers Squibb's Senior Management Team, which is responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management. Currently, the Board has one executive director and ten independent directors.

James Cornelius James M. Cornelius Chairman View biography
Lamberto Andreotti Lamberto AndreottiChief Executive OfficerView biography
Lewis B. Campbell Lewis B. Campbell Retired Chairman, Textron Inc.View biography
Louis J. Freeh Louis J. Freeh Senior Managing Partner,
Freeh Group International View biography
Laurie H. Glimcher Laurie H. GlimcherProfessor of Immunology, Harvard School of Public Health, & Professor of Medicine, Harvard Medical School View biography
Michael Grobstein Michael Grobstein Retired Vice Chairman,
Ernst & Young View biography
Alan J. Lacy Alan J. Lacy Senior Advisor,
Oak Hill Capital Partners View biography
Vicki L. Sato Vicki L. Sato Professor of Management Practice, Harvard Business School, and Professor of Molecular & Cell Biology, Harvard University View biography
Elliott Sigal Elliott Sigal, M.D., Ph.D. Executive Vice President,
Chief Scientific Officer and
President, R&D View biography
Gerald L. StorchGerald L. Storch Chairman and Chief Executive
Officer of Toys"R"Us, Inc. View biography
Togo D. West Togo D. West, Jr. Chairman, TLI Leadership
Group & Noblis, Inc. View biography
R. Sanders Williams R. Sanders Williams President, Robert W. and Linda L. Mahley Distinguished Professor, The J. David Gladstone Institutes and Professor of Medicine, University of California, San Francisco View biography